DK1214088T3 - Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner - Google Patents

Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner

Info

Publication number
DK1214088T3
DK1214088T3 DK00928851T DK00928851T DK1214088T3 DK 1214088 T3 DK1214088 T3 DK 1214088T3 DK 00928851 T DK00928851 T DK 00928851T DK 00928851 T DK00928851 T DK 00928851T DK 1214088 T3 DK1214088 T3 DK 1214088T3
Authority
DK
Denmark
Prior art keywords
bcg
mycobacterium tuberculosis
vaccines
proteins expressed
diagnostic reagents
Prior art date
Application number
DK00928851T
Other languages
English (en)
Inventor
Maria L Gennaro
Original Assignee
Univ New Jersey Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22454351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1214088(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ New Jersey Med filed Critical Univ New Jersey Med
Application granted granted Critical
Publication of DK1214088T3 publication Critical patent/DK1214088T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
DK00928851T 1999-05-04 2000-05-04 Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner DK1214088T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13250599P 1999-05-04 1999-05-04
PCT/US2000/012257 WO2000066157A1 (en) 1999-05-04 2000-05-04 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines

Publications (1)

Publication Number Publication Date
DK1214088T3 true DK1214088T3 (da) 2009-08-24

Family

ID=22454351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00928851T DK1214088T3 (da) 1999-05-04 2000-05-04 Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner

Country Status (10)

Country Link
US (12) US7932373B1 (da)
EP (2) EP2087906A1 (da)
JP (1) JP4820489B2 (da)
AT (1) ATE429245T1 (da)
AU (1) AU773268B2 (da)
CA (1) CA2372583C (da)
DE (1) DE60042078D1 (da)
DK (1) DK1214088T3 (da)
ES (1) ES2326257T3 (da)
WO (1) WO2000066157A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087906A1 (en) 1999-05-04 2009-08-12 The University of Medicine and Dentistry of New Jersey Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
CA2405247A1 (en) * 2000-04-19 2001-10-25 Statens Serum Institut Tuberculosis antigens and methods of use thereof
DE60236573D1 (de) * 2002-04-05 2010-07-15 Pasteur Institut Identifizierung der Virulenz-assoziierten Regionen RD1 und RD5, die die Entwicklung von verbesserten Impfstoffen mit M. bovis BCG und M. microti ermöglicht
AU2003224313A1 (en) * 2002-04-27 2003-11-17 The Secretary Of State For Environment, Food And Rural Affairs Mycobacterial antigens and uses thereof
GB0229444D0 (en) * 2002-12-18 2003-01-22 Royal Free Hampstead Nhs Trust Diagnostic method and assay kit
ES2534428T3 (es) 2005-07-26 2015-04-22 Rutgers, The State University Of New Jersey Perfiles de anticuerpos específicos de un estado tuberculoso
US8465753B2 (en) * 2007-04-23 2013-06-18 Robert J. Greenstein Combination vaccines against Mycobacterium sp. and methods of using the same
BRPI0708865A8 (pt) * 2006-03-14 2019-01-22 Univ Oregon Health & Science métodos para produzir uma resposta imune à tuberculose
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
CA2668100C (en) * 2006-11-01 2014-12-23 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
EP2812704A4 (en) 2012-02-07 2016-03-23 Intuitive Biosciences Inc KOCH BACILLUS SPECIFIC PEPTIDES FOR THE DETECTION OF INFECTION OR IMMUNIZATION IN NON-HUMAN PRIMATES
CN104628834B (zh) * 2015-01-23 2016-03-23 中国疾病预防控制中心传染病预防控制所 一种结核感染t细胞免疫检测抗原及其应用
EP3555630B1 (en) 2016-12-14 2023-05-31 Becton, Dickinson and Company Methods and compositions for obtaining a tuberculosis assessment in a subject

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977263A (en) 1992-12-10 1999-11-02 3M Innovative Properties Company Thermal transfer compositions, articles and graphic articles made with same
HU227778B1 (en) * 1995-09-01 2012-02-28 Corixa Corp Immogen peptid of m. tuberculosis origin, therapeutic and diagnostic use thereof
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
PT2154248E (pt) * 1995-09-01 2012-01-16 Corixa Corp Compostos e métodos para diagnóstico de tuberculose
ES2152419T3 (es) 1995-09-08 2001-02-01 Textilma Ag Telar.
IL129389A0 (en) 1996-10-11 2000-02-17 Corixa Corp Compounds and methods for diagnsosis of tuberculosis
AU740545B2 (en) 1997-04-02 2001-11-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
WO1999004005A1 (en) 1997-07-16 1999-01-28 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
US6291190B1 (en) 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
EP2087906A1 (en) 1999-05-04 2009-08-12 The University of Medicine and Dentistry of New Jersey Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
CA2405247A1 (en) 2000-04-19 2001-10-25 Statens Serum Institut Tuberculosis antigens and methods of use thereof
AU2003224313A1 (en) 2002-04-27 2003-11-17 The Secretary Of State For Environment, Food And Rural Affairs Mycobacterial antigens and uses thereof
US20070024122A1 (en) * 2005-07-27 2007-02-01 Steve Belson System and method for a distributed front end rectifier power system

Also Published As

Publication number Publication date
US20110052637A1 (en) 2011-03-03
EP1214088B1 (en) 2009-04-22
US20130149719A1 (en) 2013-06-13
US9844604B2 (en) 2017-12-19
JP2003519467A (ja) 2003-06-24
US20160169888A1 (en) 2016-06-16
CA2372583A1 (en) 2000-11-09
US20100016415A1 (en) 2010-01-21
US8021832B2 (en) 2011-09-20
US20130251739A1 (en) 2013-09-26
JP4820489B2 (ja) 2011-11-24
US9238066B2 (en) 2016-01-19
US8992942B2 (en) 2015-03-31
ATE429245T1 (de) 2009-05-15
US20160153986A1 (en) 2016-06-02
EP2087906A1 (en) 2009-08-12
US20070224123A1 (en) 2007-09-27
US9782495B2 (en) 2017-10-10
DE60042078D1 (de) 2009-06-04
CA2372583C (en) 2012-07-10
ES2326257T3 (es) 2009-10-06
EP1214088A4 (en) 2003-06-11
AU773268C (en) 2000-11-17
US8623609B2 (en) 2014-01-07
US20070224122A1 (en) 2007-09-27
US9482671B2 (en) 2016-11-01
AU4702300A (en) 2000-11-17
EP1214088A1 (en) 2002-06-19
WO2000066157A1 (en) 2000-11-09
US20170043038A1 (en) 2017-02-16
US20120107247A1 (en) 2012-05-03
AU773268B2 (en) 2004-05-20
US20140220600A1 (en) 2014-08-07
US7932373B1 (en) 2011-04-26
US7709211B2 (en) 2010-05-04
US8974800B2 (en) 2015-03-10
US7579141B2 (en) 2009-08-25

Similar Documents

Publication Publication Date Title
DK1093517T3 (da) Neisseria-meningitidis-antigener og præparater
DK1214088T3 (da) Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
NO20041428L (no) Oksazolidinon og/eller isoksazolin som antibakterielle midler.
DK1047784T3 (da) Neissera meningitidis-antigener
GB0103424D0 (en) Gonococcus proteins
DK1171417T3 (da) Fremgangsmåde til fremstilling af 3-aryloxy-3-arylpropylaminer og mellemprodukter deraf
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
NO20005050D0 (no) Fusjonsproteiner fra Mycobacterium Tuberculosis-antigener og deres anvendelse
MXPA03009415A (es) ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
DK1992635T3 (da) Oligonukleotider med immunstimulatorisk sekvens og fremgangsmåder til anvendelse af disse
DE69841807D1 (de) Neisseriale antigene
EP2360180A3 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DE69737956D1 (de) CD8 Tuberkulose Impfstoffe
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
DK1265911T3 (da) 17-alfa-substitueret-11-beta-substitueret-4-aryl og 21-substitueret 19-norpregnadiendion som antiprogestationelle midler
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DK1705183T3 (da) Bindingsmolekyler for human faktor VIII og faktor VIII-lignende proteiner
DE60042816D1 (de) T-helferzellen-epitope
NO20003261D0 (no) Blandinger avledet fra Mycobacterium vaccae og fremgangsmÕter for deres anvendelse
EP1117436A4 (en) NEISSERIA SPP. POLYPEPTIDES, NUCLEIC ACID SEQUENCE AND THEIR USE
TR200003467T2 (tr) Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar
DK1390516T3 (da) Hidtil ukendte ekspressionsvektorer og anvendelser deraf
WO2000066143A8 (en) Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
NO20032584D0 (no) Sekvenser oppströms for CARP-genet, vektorer inneholdende disse og anvendelse av disse